Items where Author is "Waxman, J"
 | Up a level |
Article
Brooke, GN and Gamble, SC and Hough, MA and Begum, S and Dart, DA and Odontiadis, M and Powell, SM and Fioretti, FM and Bryan, RA and Waxman, J and Wait, R and Bevan, CL (2015) 'Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells.' Molecular and Cellular Proteomics, 14 (5). 1201 - 1216. ISSN 1535-9476
Brooke, GN and Powell, SM and Lavery, DN and Waxman, J and Buluwela, L and Ali, S and Bevan, CL (2014) 'Engineered repressors are potent inhibitors of androgen receptor activity.' Oncotarget, 5 (4). 959 - 969. ISSN 1949-2553
Sita-Lumsden, A and Fletcher, CE and Dart, DA and Brooke, GN and Waxman, J and Bevan, CL (2013) 'Circulating nucleic acids as biomarkers of prostate cancer.' Biomarkers in Medicine, 7 (6). 867 - 877. ISSN 1752-0363
Ottaviani, S and Brooke, GN and O'Hanlon-Brown, C and Waxman, J and Ali, S and Buluwela, L (2013) 'Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells.' Journal of Molecular Endocrinology, 51 (3). 301 - 312. ISSN 0952-5041
Dart, DA and Brooke, GN and Sita-Lumsden, A and Waxman, J and Bevan, CL (2012) 'Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens.' Oncogene, 31 (43). 4588 - 4598. ISSN 0950-9232
Brooke, GN and Culley, RL and Dart, DA and Mann, DJ and Gaughan, L and McCracken, SR and Robson, CN and Spencer-Dene, B and Gamble, SC and Powell, SM and Wait, R and Waxman, J and Walker, MM and Bevan, CL (2011) 'FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth.' Cancer Research, 71 (3). 914 - 924. ISSN 0008-5472
Gamble, SC and Chotai, D and Odontiadis, M and Dart, DA and Brooke, GN and Powell, SM and Reebye, V and Varela-Carver, A and Kawano, Y and Waxman, J and Bevan, CL (2007) 'Prohibitin, a protein downregulated by androgens, represses androgen receptor activity.' Oncogene, 26 (12). 1757 - 1768. ISSN 0950-9232